Compile Data Set for Download or QSAR
maximum 50k data
Found 28 Enz. Inhib. hit(s) with all data for entry = 11058
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588192((S)-(4-(3-Cyclohexyl-4-(pyrrolidin-3- yloxy)benzoy...)
Affinity DataKi:  5.20E+3nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588210(US11542254, Example canosic acid)
Affinity DataKi:  5.30E+3nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588205(4-(3-((S)-3-Ethyl-4-(4'-fluoro-6- (((S)-pyrrolidin...)
Affinity DataKi:  1.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588209((S)-1-(3-Fluoro-5-(4-(4-(pyrrolidin- 3-yloxy)-3-(4...)
Affinity DataKi:  1.40E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588194((S)-(4-(3-Fluoro-5-(piperazin-1-yl) methylcyclohex...)
Affinity DataKi:  1.60E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588184(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  1.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588184(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  2.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588207(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  2.20E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588201((S)-(4-(3-Cyclohexyl-4-(pyrrolidin- 3-yloxy)benzoy...)
Affinity DataKi:  2.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588189((4-(3-Fluoro-5-(((R)-pyrrolidin-3- yl)oxy)benzoyl)...)
Affinity DataKi:  3.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588193((S)-(4-(3-Cyclopentyl-4- (pyrrolidin-3-yloxy)benzo...)
Affinity DataKi:  3.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588208((S)-1-(3-(4-(3-Cyclohexyl-4- (pyrrolidin-3-yloxy)b...)
Affinity DataKi:  3.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588197((S)-(4-(3-(4,4- Dimethylcyclohexyl)-4-(pyrrolidin-...)
Affinity DataKi:  4.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588206(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  4.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588188((4-(3-Fluoro-5-(((S)-pyrrolidin-3- yl)oxy)benzoyl)...)
Affinity DataKi:  4.80E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588198((S)-(4-(3-(4,4-Difluorocyclohexyl)- 4-(pyrrolidin-...)
Affinity DataKi:  5.30E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588203((S)-(4-(3-Bromo-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  5.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588191((S)-(4-(3',4'-Difluoro-6-(pyrrolidin- 3-yloxy)-[1,...)
Affinity DataKi:  5.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588187((S)-(4-(3-(2-Aminoethyl)-5- fluorobenzoyl)piperazi...)
Affinity DataKi:  6.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588202((S)-(4-(3-Cyclohexyl-4-(pyrrolidin- 3-yloxy)benzoy...)
Affinity DataKi:  6.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588196((S)-(4-(3-(4-Ethylcyclohexyl)-4- (pyrrolidin-3-ylo...)
Affinity DataKi:  7.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588200((S)-(4-(3-Chloro-5-(piperazin-l-yl) benzoyl)pipera...)
Affinity DataKi:  7.60E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588185((S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)pipera...)
Affinity DataKi:  8.20E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588204(4-(3-Fluoro-5-((S)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  1.10E+5nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588183(2-((5-carbamoyl-4'-fluoro-[1,1'- biphenyl]-2-yl)ox...)
Affinity DataKi:  1.30E+5nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588195((S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)pipera...)
Affinity DataKi:  1.70E+5nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588199((S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)pipera...)
Affinity DataKi:  4.90E+5nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Homo sapiens (Human))
Universisity Of Utah Research Foundation

US Patent
LigandPNGBDBM588186((S)-(4-(3-(2-Aminoethyl)-5- fluorobenzoyl)piperazi...)
Affinity DataKi: >5.00E+5nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent